Hotnewstoday360: The scientists from the Organization Kaiser Permanente Southern California (KPSC) conducted data analysis for cancer patients in KPSC recorded in 2008-2012, of which have HCV and not HCV infected at age 18 or older.
The study results showed that HCV-infected patients not only risk being "attacked" by liver cancer but also many other cancers such as non-Hodgkin's lymphoma (non-Hodgkin's lymphoma), kidney cancer, prostate cancer ...
The team has identified, among 2,213 cancer patients with HCV infection, exclusion of people with liver cancer, the remaining 1,654 patients suffering from other cancers.
Of the 84 419 cancer patients not infected with HCV, after exclusion of patients with liver cancer, about 83 795 people with other cancers, "attack".
Based on the results of this research, scientists have calculated that, in HCV-risk liver cancer 2.5 times higher than non-infected with HCV, after excluding cancer liver, the proportion of patients infected with HCV were "attacked" by other cancers than 2 times higher than non-infected with HCV.
Dr. Lisa Nyberg - who led the study said, "The results of this study showed that the rate of cancer is higher in patients with hepatitis C, so there is a huge correlation between hepatitis C and risk of cancer. It is also seen as a warning to us to prevent and limit the factors that may cause hepatitis C at the lowest level. "
Dr. Laurent Castera - Deputy Secretary of the European Association for the Study of Liver stressed that "there is still a long way for us to do more research to find more effective treatment method based hepatitis C is complex and risky. "
As known, earlier, reported Medical News Today has reported on a study published in the journal Science Translational Medicine, said a vaccine against hepatitis C were the scientists of Oxford University (UK) clinical trials in phase 1 showed promising results, current vaccines are also promoted tested in the next phase.